Primary Functions
- Fine-line appearance direction
- Smoother-looking skin direction
- Firming and peptide-led age support
Ingredient directions
Palmitoyl Pentapeptide-4 Skincare Development
Palmitoyl Pentapeptide-4 Skincare Formulation and Manufacturing
Develop private label or custom Palmitoyl Pentapeptide-4 skincare around the exact pal-KTTKS material, peptide active basis, carrier or commercial solution, delivery strategy, formula compatibility, stability, sensory target, packaging, evidence, and destination market. Matrixyl-branded systems should be verified by their full current INCI rather than treated as concentration-equivalent to every Palmitoyl Pentapeptide-4 raw material.
Ingredient Snapshot
At a Glance
Buyer Value
- Useful for facial serum and moisturizer briefs built around a recognizable signal-peptide direction
- Exact peptide basis carrier vehicle delivery stability and finished-product evidence should be reviewed early
Best-Fit Product Formats
Material Note
Confirm the exact Palmitoyl Pentapeptide-4 identity, assay or peptide basis, carrier and preservative system, supplied form, storage, and supplier technical guidance before formulation.
Ingredient Direction
What Is Palmitoyl Pentapeptide-4?
Palmitoyl Pentapeptide-4 is a synthetic palmitoylated pentapeptide with the sequence commonly abbreviated pal-KTTKS. Older identity records may also map the name Palmitoyl Pentapeptide-3 to the same substance. It is used in cosmetic skin-conditioning and appearance-focused peptide formulations.
“Matrixyl®” should not be treated as a generic concentration synonym for every Palmitoyl Pentapeptide-4 material. Croda’s current original Matrixyl commercial product is a multi-ingredient liquid system containing Glycerin, Water, Butylene Glycol, Carbomer, Polysorbate 20, and Palmitoyl Pentapeptide-4. Confirm the exact supplier material and peptide active basis before comparing percentages or evidence.
For family-level selection context, see Peptides.
Concept Development
Why Brands Consider Palmitoyl Pentapeptide-4 Skincare
Pal-KTTKS has direct finished-product clinical evidence, but claims still need to stay proportional to the formula actually tested.
Fine-Line Appearance
A 12-week double-blind split-face study in 93 women found significant fine-line and wrinkle improvement with a specific moisturizer containing pal-KTTKS versus its control moisturizer.
Smoother-Looking Skin
A later randomized study in 21 women also reported improvement with a Palmitoyl Pentapeptide-4 cream around crow’s feet, supporting smoothing as a relevant cosmetic direction while recognizing the small sample size.
Firming and Age-Support Positioning
Mechanistic and clinical literature make pal-KTTKS suitable for firming and age-support briefs, but avoid promising collagen rebuilding or structural repair from an untested finished cosmetic.
Recognizable Peptide Story
The ingredient offers a distinct signal-peptide direction for brands that want a peptide-led serum or moisturizer without relying on retinoid positioning.
Format Selection
Products You Can Make With Palmitoyl Pentapeptide-4
Select the format together with the exact peptide grade, carrier system, vehicle, supporting actives, sensory target, and package.
| Product Format | Development Direction | Review First |
|---|---|---|
| Facial Serums | Water-based, emulsion-serum, or peptide-combination direction | Peptide basis, carrier, phase placement, vehicle, preservation, delivery, and dispenser |
| Moisturizers | Emulsion with fine-line, smoothing, and firming positioning | Commercial solution, water phase, emulsifier system, compatibility, stability, and package |
Formulation Notes
What to Confirm Before Sampling
Palmitoyl Pentapeptide-4 development depends on the exact peptide basis, vehicle, delivery, and finished-formula stability rather than the ingredient name alone.
Confirm Peptide Identity and Active Basis
Review INCI, pal-KTTKS identity, assay or active basis, carrier, preservatives, supplied form, storage, and batch documentation. A commercial solution percentage is not automatically the same percentage of Palmitoyl Pentapeptide-4.
Design the Vehicle for Peptide Delivery
Palmitoylation improved skin-layer distribution compared with unmodified KTTKS in experimental mouse skin, but neither peptide crossed the full-thickness skin under those test conditions. Vehicle and delivery assumptions should therefore be validated rather than inferred.
Validate Formula Availability and Stability
Analytical research shows cosmetic formulation can influence measurable pal-KTTKS availability. Confirm phase placement, processing temperature, pH, preservatives, surfactants, polymers, other actives, and real-time stability with the selected material.
Keep Claims Formula-Specific
Clinical studies support fine-line appearance for defined products, but multi-active regimens and supplier studies cannot establish identical efficacy for a new OEM serum or moisturizer. Match final claims to finished-product substantiation.
Technical references checked September 10, 2026: FDA substance identity record, CIR safety assessment, 12-week pal-KTTKS clinical study, dermal stability and permeation study, cosmetic formulation assay study, and current Matrixyl commercial product reference. These sources do not establish universal use levels, processing conditions, delivery performance, or finished-product claims.
Start With the Exact Palmitoyl Pentapeptide-4 Material
Discuss Your Palmitoyl Pentapeptide-4 Skincare Project
Share your Palmitoyl Pentapeptide-4 material reference, peptide active basis, carrier or commercial solution, target product format, intended level, supporting ingredients, texture, packaging, quantity, destination market, and cosmetic positioning. Rixin can review the formulation route and the questions to resolve before sampling.